(-0.06%) 5 475.25 points
(-0.11%) 38 774 points
(0.00%) 19 921 points
(0.15%) $80.45
(1.43%) $2.83
(0.21%) $2 333.90
(-0.16%) $29.35
(-0.18%) $969.20
(0.00%) $0.932
(-0.19%) $10.63
(0.04%) $0.787
(-1.87%) $86.80
Live Chart Being Loaded With Signals
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases...
Stats | |
---|---|
Šios dienos apimtis | 80 639 |
Vidutinė apimtis | 90 334 |
Rinkos kapitalizacija | 415.01M |
EPS | $-10.50 ( Q1 | 2024-03-31 ) |
Kita pelno data | ( $-0.810 ) 2024-08-15 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.162 (0.69%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-09 | English Emily | Sell | 0 | Common Stock |
2024-04-09 | English Emily | Sell | 14 254 | Stock Option (Right to Buy) |
2024-04-09 | English Emily | Sell | 23 433 | Stock Option (Right to Buy) |
2024-04-08 | Singer Michael | Buy | 377 208 | Common Stock |
2024-04-08 | Singer Michael | Buy | 110 151 | Common Stock |
INSIDER POWER |
---|
75.69 |
Last 44 transactions |
Buy: 16 103 370 | Sell: 2 254 554 |
Tūris Koreliacija
Cartesian Therapeutics, Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Cartesian Therapeutics, Koreliacija - Valiuta/Žaliavos
Cartesian Therapeutics, Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $26.00M |
Bruto pelnas: | $24.45M (94.03 %) |
EPS: | $-42.58 |
FY | 2023 |
Pajamos: | $26.00M |
Bruto pelnas: | $24.45M (94.03 %) |
EPS: | $-42.58 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Cartesian Therapeutics,
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company\'s lead therapeutic gene therapy program is SEL-302 that is in Phase I clinical trial to enhance the treatment of methylmalonic acidemia. It is also developing biologic therapies, such as SEL-212 that is in Phase III clinical trials for the treatment of chronic refractory gout; and product candidates to treat IgA-mediated diseases, including IgA nephropathy, linear IgA bullous dermatitis, IgA pemphigus, and Henoch-Schonlein purpura. In addition, the company is developing gene therapies comprising for the treatment of pompe disease, duchenne muscular dystrophy, limb-girdle muscular dystrophy, lysosomal storage disorder, and other autoimmune diseases. Further, it develops tolerogenic therapies to treat autoimmune diseases. The company has license and collaboration agreements with Ginkgo Bioworks Holdings, Inc.; Genovis AB (publ.); Cyrus Biotechnology, Inc.; IGAN Biosciences, Inc.; Astellas Therapeutics, Inc.; Takeda Pharmaceuticals USA, Inc.; Swedish Orphan Biovitrum AB (publ.); Sarepta Therapeutics, Inc.; Asklepios Biopharmaceutical, Inc.; Massachusetts Institute of Technology; and Shenyang Sunshine Pharmaceutical Co., Ltd. Selecta Biosciences, Inc. was incorporated in 2007 and is headquartered in Watertown, Massachusetts.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.